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ABSTRACT
Zinc is recommended for the treatment of acute diarrhea in
children but the effect of its introduction on drug and oral
rehydration solution use is unclear. Government care providers,
private practitioners and community workers were trained to
distribute zinc and oral rehydration solution to children seeking
care for diarrhea. Periodic surveys showed that village-based
workers became a common source of diarrhea treatment and
private practitioners were used less. Zinc was used in
approximately half of the episodes; the prescription and use
rates of oral rehydration solution packets increased from 7% at
baseline to 44.9% 6 months later. Reduction in use of drugs
during diarrhea ranged from 34% for tablets to 64% for
injections 6 months later. The cost of treatment to families
declined significantly. These findings need confirmation in
a randomized controlled trial. JPGN 41:685–687, 2005. Key
Words: Zinc, diarrhea, oral rehydration salts, care providers.
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INTRODUCTION
Placebo-controlled efficacy trials using zinc supple-
ments to treat acute diarrhea along with oral rehydration
solution (ORS) therapy in young children have shown
a significant reduction in the duration of treated episodes
and their severity as measured by diarrhea stool output or
frequency (1,2). Diarrheal and respiratory morbidity
were also reduced over 4 to 8 weeks after recovery from
the zinc treated diarrheal episode (3). Because of sub-
stantial intestinal losses of zinc during acute diarrhea, it
is likely that zinc deficiency develops in children during
the illness and immediately following it and this may
explain the beneficial impact even after discontinuation
of the supplement (3).
These trials were done in developing countries,
including India. Subsequent to World Health Organiza-
tion recommendations (4), the Indian Academy of Pe-
diatrics also endorsed zinc use for 10 to 14 days during an
episode of acute diarrhea in children aged 1 month to
5 years (5).
The issue now is whether zinc should be introduced
in primary healthcare programs for treatment of acute
diarrhea. Although the evidence for efficacy is strong,
information is required on how the introduction of zinc
will affect ORS use rates and drug and antibiotic pre-
scription by healthcare providers during diarrhea. We
therefore conducted a pilot study where zinc was dis-
tributed to young children with diarrhea seeking care
from public or private sectors in a rural setting.
PATIENTS AND METHODS
The setting was the primary health center of Tigaon
(population ;33000) in Faridabad district in the state of
Haryana, India. Formative research identified perceptions of
caregivers regarding childhood diarrhea causation and man-
agement, care seeking sources and caregivers expectations from
healthcare providers. Caregivers in households with children
under 5 years old were interviewed in a cross-sectional survey
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to ascertain family characteristics, ORS prescription and use
rates, drug prescription rates by healthcare providers and other
variables of interest. In partnership with the local government,
channels for distribution of zinc and ORS packets were defined.
These included government providers (physicians and auxiliary
nurse midwives at the primary health center), private practi-
tioners and community workers—the ‘‘Anganwadi workers’’
under the Integrated Child Development Services Scheme of
the Government of India; these workers do not treat diarrhea
routinely. All channels were trained in diarrhea management,
zinc distribution and use, and referral criteria, over a 2-day
training period. The strategy was to give one strip containing 14
dispersible zinc tablets (20 mg each) along with 2 ORS packets
to all children aged 1 month to 5 years visiting that channel with
diarrhea. Infants aged less than 6 months were advised half
a zinc tablet in a teaspoonful of breast milk; older children were
advised 1 tablet in breast milk or clean water. After the training,
project staff had no role in patient treatment. The messages
imparted were carefully designed based on findings of the
formative research. The effectiveness of this pilot program was
assessed through two cross-sectional surveys, 3 and 6 months
post-training.
Approvals were obtained from the ethical review boards of
all participating institutions.
RESULTS
Of the total of 5266 households served by the primary
health center, 2364 (44.9%) had one or more children
aged between 1 month and 5 years. Interviews with
caregivers could be conducted in over 95% households in
the three surveys; the remaining were away. In the base-
line survey, the median household income per year was
;USD 930. The mean (SD) years of schooling were 5.5
(4.7) for mothers and 9.0 (3.8) for fathers. Most (89%)
mothers did not work outside the home.
Table 1 shows the sources of care used and treatment
prescribed during diarrhea in the baseline and the two
subsequent surveys for diarrheal episodes occurring in
the previous 3 months. There was a shift in the source
from which care was sought as compared with baseline;
private practitioners were used less and the village-based
Anganwadi workers became a common source. Care
seeking from government facilities remained uncommon
(2% at baseline to 5%, 6 months later; Table 1). The
prescription of syrups, tablets, powders and injections
during diarrhea and cost of treatment for the episode all
decreased significantly (Table 1). Almost one third of
caregivers had incurred no financial costs for treatment
of the diarrheal illness 6 months after the start of the
intervention, as compared with 2.4% in the baseline
survey (Table 1). The prescription and use rates of ORS
packets during diarrhea increased markedly from 7% at
baseline to over 40% in the subsequent surveys (Table 2).
Zinc tablets were prescribed in more than half of epi-
sodes 6 months after the start of the intervention. When-
ever advised, zinc tablets were administered to the child
(Table 2). At the 3- and 6-months surveys, 72% and
74%, respectively, reported giving the complete 14-day
course.
DISCUSSION
Several lessons can be learnt from this pilot test. It was
feasible to train various government and community
channels and to promote zinc as a treatment for acute
diarrhea through the primary healthcare system. Zinc
tablets were well accepted by caregivers and children.
Introduction of zinc did not reduce ORS use rates when
both were promoted together. Sources close to home
(Anganwadi workers and private providers) were pre-
ferred by families. Use of drugs, not routinely recom-
mended for the treatment of acute diarrhea (4), declined,
possibly because of the effect of zinc treatment in
TABLE 1. Care seeking sources and treatment advised by them during diarrheal episodes in children aged 1 month to 5 years
Cross-sectional surveys P value
Baseline After 3 months After 6 months Baseline vs 3 mo‡ Baseline vs 6 mo‡
Source of care (n = 797)* (n = 1988)* (n = 1030)*
Primary health center 19 (2.4) 81 (4.1) 57 (5.5) 0.040 0.001
Private practitioners 648 (81.3) 1158 (58.2) 580 (56.3) ,0.0001 ,0.0001
Anganwadi workers 3 (0.4) 510 (25.6) 266 (25.8) ,0.0001 ,0.0001
From outside the village 127 (15.9) 239 (12.0) 127 (12.3) 0.007 0.032
Treatment advised (n = 739)† (n = 1717)† (n = 909)†
Syrups; identity unknown 671 (91) 1033 (60.2) 511 (56.2) ,0.0001 ,0.0001
Tablets; identity unknown 178 (24.1) 248 (14.4) 142 (15.6) ,0.0001 ,0.0001
Powders; identity unknown 545 (74) 763 (44.4) 369 (40.6) ,0.0001 ,0.0001
Injections; identity unknown 428 (58) 564 (32.8) 190 (20.9) ,0.0001 ,0.0001
Antibiotics and antidiarrheals 45 (6.1) 125 (7.3) 89 (9.8) 0.327 0.008
Total cost in Rupees; mean (SD) 113 (411) 59 (363) 48 (177) 0.002§ 0.0001§
Incurred no financial costs; n (%) 20 (2.7) 452 (26.3) 269 (29.6) ,0.0001 ,0.0001
*Number of sources visited.
†Number of episodes in the last 3 months.
‡x2 test.
§t-test for unequal variance.
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reducing illness severity and duration, the availability of
treatment in the village itself and reduced contact with
private practitioners. These findings should be confirmed
in cluster randomized controlled trials where communi-
ties receiving zinc and ORS packets for treatment of
diarrhea are compared with those receiving ORS alone,
including impact on additional outcomes such as diarrhea
hospitalization rates and mortality.
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TABLE 2. Healthcare providers advice and caregivers practices regarding oral rehydration solution packets and zinc
Cross-sectional surveys P value
Baseline After 3 months After 6 months Baseline vs 3 mo* Baseline vs 6 mo*
Number of episodes 739 1717 909
Healthcare providers advice
ORS packets 54 (7.3) 809 (47.1) 409 (44.9) ,0.0001 ,0.0001
Zinc tablets – 852 (49.6) 472 (51.9)
Caregiver practices
ORS administered 54 (7.3) 728 (42.4) 393 (43.2) ,0.0001 ,0.0001
Zinc administered – 839 (48.9) 469 (51.6)
All values are n (%).
*x2 test.
ORS, oral rehydration solution.
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